secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK:        0001314052
Form:       8-K
Filed at:   2026-07-20T12:59:34+00:00
Accession:  0001731122-26-000957
Event type: regulatory
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Anavex submits Nasdaq compliance plan to regain listing after late Q1 filing
----------------------------------------------------------------------------

- Submitted compliance plan on July 20, 2026 to Nasdaq Staff regarding late Form 10-Q for March 31, 2026.
- Plan addresses non-compliance with Nasdaq Listing Rule 5250(c)(1) for timely periodic reports.
- Nasdaq Staff reviewing plan; if accepted, extension may be granted; if not, hearing available.
- No immediate effect on listing; common stock continues trading on Nasdaq under symbol AVXL.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1314052/000173112226000957/0001731122-26-000957-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1314052/000173112226000957/e7790_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-26-000957

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer